Targeting the ATM pathway for the treatment of CLL
1 Visualizações
• 06/24/23
0
0
Embutir
administrator
Assinantes
Tatjana Stankovic, MD, PhD, University of Birmingham, Birmingham, UK discusses recent findings in the ataxia-telangiectasia mutated (ATM) pathway including targeting this pathway in Chronic Lymphocytic Leukemia (CLL). This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.
Mostre mais
Comentários do Facebook
SORT BY-
Melhores Comentários
-
Últimos Comentários